North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 1 to 15 of 15
Details
UPD
sitematrix Changed from 0 to
11/07/2023 17:46:21
(dmcdermott )
UPD
FurtherInformation Changed from
Approved for use in accordance with NICE and NHS EnglandCommissioning Policy
to
Approved for use in accordance with NICE and NHS EnglandCommissioning Policy
11/07/2023 17:46:21
(dmcdermott )
UPD
Dasatinib (Sprycel
®
) =
11/07/2023 17:46:21
(dmcdermott )
LDL
Link Added : MHRA Drug Safety Update (May 2016): BCR-ABL tyrosine kinase inhibitors: risk of hepatitis B reactivation : https://www.gov.uk/drug-safety-update/bcr-abl-tyrosine-kinase-inhibitors-risk-of-hepatitis-b-reactivation
11/07/2023 17:45:59
(dmcdermott )
UPD
sitematrix Changed from 0 to
17/12/2021 12:31:23
(LoweryM )
UPD
FurtherInformation Changed from
Approved for use in accordance with NICE and NHS Commissioning Policy
to
Approved for use in accordance with NICE and NHS EnglandCommissioning Policy
17/12/2021 12:31:23
(LoweryM )
UPD
Dasatinib (Sprycel
®
) formatting
17/12/2021 12:31:23
(LoweryM )
UPD
Dasatinib (Sprycel
®
) Updated
09/08/2017 16:09:46
(DavidS )
UPD
Dasatinib (Sprycel
®
) B
03/02/2017 14:50:21
(LoweryM )
LDL
Link Added : NICE TA426: Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia : https://www.nice.org.uk/guidance/ta426/
31/01/2017 16:06:10
(DavidS )
UPD
Dasatinib (Sprycel
®
) b
31/01/2017 16:05:03
(DavidS )
LDL
Link Added : NICE TA425: Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia : https://www.nice.org.uk/guidance/ta425
31/01/2017 16:03:30
(DavidS )
UPD
Dasatinib (Sprycel
®
) b
31/01/2017 16:03:02
(DavidS )
UPD
Dasatinib (Sprycel
®
) b
23/01/2017 15:37:39
(WhitehallJ )
UPD
Dasatinib (Sprycel
®
) build
28/11/2016 15:40:36
(DavidS )